ARBOR BIOTHECHNOLOGIES

HQ - Cambridge, MA

Summary

Arbor Bio is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic editors in the industry.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 57 M

Avg. Deal Size£ 57 M

Market Context

Senior Management

Devyn Smith
CEO